
DFMO shows promise in reducing metastasis in osteosarcoma and Ewing sarcoma, with phase 2 trials underway to test its role as maintenance therapy.

Your AI-Trained Oncology Knowledge Connection!


Rachel Offenbacher, MD, is an attending physician in the Division of Pediatric Hematology, Oncology, and Cellular Therapy Children’s Hospital at Montefiore. She is an assistant professor in the Department of Pediatrics at Albert Einstein College of Medicine and a member of Montefiore Einstein Comprehensive Cancer Center in Bronx, NY.

DFMO shows promise in reducing metastasis in osteosarcoma and Ewing sarcoma, with phase 2 trials underway to test its role as maintenance therapy.